Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Possible Legislation Regarding ESA Administration On The Horizon

Executive Summary

A recent report from the HHS Office of Inspector General regarding erythropoiesis-stimulating agent administration to patients with chronic kidney failure could be laying the foundation for legislative action in the coming year, a staffer for House Ways and Means Health Subcommittee Chairman Pete Stark, D-Calif., said
Advertisement

Related Content

Access To ESRD Drugs Under Bundled Medicare Payments Concerns GAO
Access To ESRD Drugs Under Bundled Medicare Payments Concerns GAO
CMS Defends Oral ESRD Drug Inclusion In Proposed Bundling Rule
ESRD Bundling Debate Shifts To Congress With Receipt Of CMS Report
ESRD Bundling Debate Shifts To Congress With Receipt Of CMS Report

Topics

Advertisement
UsernamePublicRestriction

Register

PS051677

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel